viva healthcare packaging et. al. v. ctl packaging et. al

7/30/2019 Viva Healthcare Packaging Et. Al. v. CTL Packaging Et. Al.

1/40

lesl;d ctX ?I 6,J-l

,llIF,z,-trzn

1

2J456789

1011T213t415T6t71819202l22232425262728

&082s62198603

L.L.P

UNITED STATES DISTRICT COURTCENTRAL DISTRICT OF CALIFORNIA

600 Anton Blvd. Suite 1400Costa Mesa, Cafifornia 92626-7689Teleohone: 7 14.427.7000Facsimile: 714.427.7799Catherine Nyalady. (pro hac vice pending)cnv aradv ).D av lw el s s. c omAlxandel. Parker (Bar No. 264705)ao arker (n au lwe i s s. co mPAUL, \E,ISS, zuFKIND, W}IARTON &GARzuSON LLP1285 Avenue of the AmericasNew York, New York 10019-6064Tel: 212-373-3000Fax: 212-757-3990Attorneys for Plaintif Viva HealthcarePackasns. Ltd.. Viva Healthcare Packasins(Fil() Ltd7,' and Viva Healthcare Packagg"(USA) Inc.

:f,!1Il

J{'*'"t-r

Viva Healthcare Packasins Ltd.. VivaHealthcare Packasine ffil(l Ltd.. andViva Healthcare Fackaing (USA)lnc.,Plaintif,

CASE No. cv13 -$31zsvw (MRwCOMPLAINT FOR PATENTINFRINGEMENTJury Trial Demanded

CTL Packasins USA. Inc.. TuboolastHispania, a rr Pckaging,Defendant.

COMPLAINT

Case 2:13-cv-03372-SVW-MRW Document 1 Filed 05/10/13 Page 1 of 40 Page ID #:14


2/40

lesl;ral

lF,zJJt!zV)

12J456789

1011I213t415t6t718T9202t22232425262728

Plaintif Viva Healthcare Packaging Ltd. ("Viva"), Viva HealthcarePackaging (Fil() Ltd. ("Viva HK"), and Viva Healthcare Packaging (USA) Inc.("Viva IJSA", and collectively "Plaintiffs") allege against CTL Packaging USA,Inc. ("CTL USA"), Tuboplast Hispania, and CTL Packaging (collectively,"Tuboplast CTL Defendants") as follows:

JURISDICTION AND VENUE1. This is an action for patent infringement arising under the patent lawsof the United States of America, Title 35 of the United States Code. This Court hassubject matter jurisdiction over this action pursuantto 28 U.S.C. $$ 1331 and1338(a).2. This Court has personal jurisdiction over the Tuboplast CTLDefendants because they, directly or through a stream of commerce, purposelydirect infringing activities at residents of this forum.3. For example, one or more of the Tuboplast CTL Defendants sellsinjection-molded tubes made using an infringing process to, among others, thecompany Zotos International. These tubes include, without limitation, the tubesused as packaging for Zotos International's AGEbeautiful brand intense hairstrengthening treatment.4. On information and belief, Tuboplast Hispania and CTL Fackaginghave manufacttrred these tubes outside the lJnited States using an infringing processand have imported said tubes into the United States for sale by CTL USA. Oninformation and belief, CTL USA manufactures these tubes inside the United Statesusing an infringing process. On information and belief, CTL USA sells these tubesto Zotos International.5. The Tuboplast CTL Defendants customize these injection-moldedtubes for Zotos International by printing the AGEbeautiful brand name on thetubes.

a COMPLAINT



3/40

glelsi z+ )tt3l

&l3F,zI!zU)

12J456789

1011t213t415T6t718T9202T22232425262728

6. The AGEbeautiful brand intense hair strengthening treatment productsare sold at Sally Beauty retail stores, among other retail establishments. There arenumerous Sally Beauty retail locations within this District. According to the SallyBeauty web site (www.sallybeauty.com), there are at least 95 Sally Beauty storeslocated within 50 miles of the zip code 90012. The AGEbeautiful brand intensehair strengthening treatment products are sold at Sally Beauty locations in thisDistrict, including at the Sally Beauty retail store located at 1250 S Vermont Ave#104, Los Angeles, CA 90006.7. The Tuboplast CTL Defendants are therefore engaged in a continuousand established distribution channel that ends in this District and through whichinjection-molded tubes made using an infringing process are sold.8. Furthermore, CTL USA maintains a West Sales Manager. Oninformation and belief, the activities of this individual include developing furthersales channels for injection-molded tubes made using an infringing process inCalifornia and in this District.g. Venue is proper in this district pursuant to 28U.S.C. $$ 1391 (b) and(c).

THE PARTIES10. Plaintiff Viva is a limited liability company organized under the lawsof the Hong Kong Special Administrative Region of the People's Republic of China("Hong Kong"). Viva's principal place of business is located at Floor 17, OneIsland South, No. 2 Heung Yip Road, Wong Chuk Hang, Hong Kong.

1 1. Plaintiff Viva HK is a limited liability company organized under thelaws of Hong Kong. Viva HK's principal place of business is located at Floor 17,One Island South, No. 2 Heung Yip Road, Wong Chuk Hang, Hong Kong.12. Plaintiff Viva USA is a corporation organized under the laws of theState of California. Viva USA's principal place of business is located at 11355 W.Olympic Blvd., Suite 300, Los Angeles, CA 90064.

- 3 - coMPLATNT



4/40

ds9l csJIeFI,i-to--itlu

12J456789

1011t213T41516l718t9202I22232425262728

13. Defendant CTL USA is a corporation organized under the laws of theState of North Carolina. On information and belief, CTL IJSA's principal place ofbusiness is located at 1055 Gastonia Technology Parkway, Dallas, NC 28034.

14. Defendant Tuboplast Hispania is, on information and belief, an entityorganized under the laws of Spain. On information and belief, TuboplastHispania's principal place of business is located at Hermanos Lumiere 1, 01510Minano (Alava), Apartado de Correos. 314, 01080 Vitoria-Gasteiz, Spain.15. Defendant CTL Packaging is, on information and beliet an entityorganized under the laws of France. On information and belief, CTL Packaging'sprincipal place of business is located at 8, Route de Vichy, 03110 Charmeil, France.16. On information and belief the Tuboplast CTL Defendants - CTLUSA, Tuboplast Hispani a, and CTL Packaging - are jointly controlled as part of aprivately owned entity known as the CTL TH Packaging Group

F'ACTUAL ALLEGATIONS17. United States Patent No. 6,547,094 ("the '094Pafent"), entitled"Injection Moulding," was duly and legally issued by the United States Patent andTrademark Office on April 15,2003. A true and corect copy of the '094 Patent isattached hereto as Exhibit A.18. Viva is the owner of the '094 Patent by virtue of an assignment andowns all rights and title to the '094Patent, including the right to sue and recover forany and all past infringement.19. Viva HK is the exclusive licensee of the '094 Patent for the territoryincluding the United States.20. Viva USA is the exclusive United States distributor of injection-molded tubes manufactured or sold by Viva HK. Viva HK cannot license any otherperson or entity to practice the '094Patent in the United States without Viva USA'sconsent. As a result, Viva USA is an implied exclusive licensee in the UnitedStates under the '094 Patent. -4- COMPLAINT



5/40

lesl5ii ciAJott z()l

tl3F,zJJr!zU)

12aJ456789

10111213T415r6t718t9202T22232425262728

2L In violation of 35 U.S.C. 271, the Tuboplast CTL Defendants havebeen and continue to be engaged in making, using, selling, offering to sell in theUnited States, and importing into tire United States injection-molded tubes thatinfringe one or more claims of the '094 Patent. These injection-molded tubesinclude without limitation the easysupplytube brand injection-molded tubes, suchas the tubes provided to Zotos International for the AGEbeautiful brand intense hairstrengthening treatment products. These tubes infringe, without limitation, at leastclaim 9 of the '094 Patent.22. In violation of 35 U.S.C.S 271, the Tuboplast CTL Defendants havebeen and continue to be engaged in the importation into the United States, offeringto sell, selling, and using in the United States injection-molded tubes made using aprocess that infringes one or more claims of the '094Patent. These injection-molded tubes include without limitation the easysupplytube brand injection-moldedtubes, such as the tubes provided to Zotos International for the AGEbeautiful brandintense hair strengthening treatment products. The Tuboplast CTL Defendantsinfringe, without limitation, at least claim 1 of the '094 Patent.23. On information and belief, in violation of 35 U.S.C. 271, TuboplastHispania and/or CTL Packaging, or an affiliated entity, manufactured in Europe atleast some of the infringing easysupplytube brand tubes that werd then sold in theUnited States by CTL USA to Zotos International. The Tuboplast CTLDefendants' infringement of the '094 Patent arises out ofthe same transaction,occurrence, or series of transactions or occurrences relating to the easysupplytubebrand injection-molded tubes, including without limitation the tubes sold to ZotosInternational.24. In violation of 35 U.S.C. 271, CTL USA is engaged in themanufacture in the United States of injection-molded tubes using a process thatinfringes one or more claims of the '094Patent. These injection-molded tubesinclude without limitation the easysupptytube brand injection-molded tubes, such

- 5 - coMPLAINT



6/40

l*i cN"r E tI -t

tF,zJ!zU)

12J456789

1011T213I415r6t718T9202l22232425262728

as the tubes provided to Zotos Intemational for the AGEbeautiful brand hairtreatment products. Without limitation, CTL USA's manufacturing of injection-molded tubes infringes at least claim 1 of the '094 Patent.

25. The Tuboplast CTL Defendants have had actual knowledge of the '094Patent at least as early as Augustz}l2,basedon communications with the formerowner of the '}94Patent, Zestron Research Pty, regarding the '094 Patent.Nevertheless, the Tuboplast CTL Defendants have continued to infringe the '094Patent.

CAUSE OF ACTTON (INFRTNGEMENT OF',094 PATENT)26. Ptaintif reallege and incorporate by reference each and everyallegation set forth in the preceding paragraphs 1 through25 as if fully set forthhere. 27. The Tuboplast CTL Defendants have committed and will continue tocommit acts that include making, using, selling, offering to sell, and importinginjection-molded tubes that infringe one or more claims of the '094 Patent, inviolation of 35 U.S.C. 271.28. The Tuboplast CTL Defendants have committed and will continue tocommit acts that include importing into the United States, offering to sell, selling,and using injection-molded tubes made using a process that infringes one or moreclaims of the '094Patent, in violation of 35 U.S.C. 5 27I.

29, CTL USA is manufacturing injection-molded tubes in the UnitedStates using a process that infringes one or more claims of the '094Patent, inviolation of 35 U.S.C. 271.30. On information and belief, Tuboplast Hispania and CTL Packaginghave and continue to knowingly and with specific intent to do so actively induceCTL USA to sell injection-molded tubes made using an infringing process and tomanufacture injection-molded tubes using an infringing process, despite havingactual knowledge that this process is both patented and infringing. On information

- 6 - coMPLAINT



7/40

r-].lF,z,lJtlzU)

":aPzrl6ots


8/40

lga: ciXr lEi5

r!F,z,lJrl]zU)

1

2J456789

101lt213T41516I718T9202l22232425262728

A. That this Court adjudge and decree that the Tuboplast CTL Defendantshave been and continue to infringe or actively induce the infringement of the '094Patent;

B. That the Tuboplast CTL Defendants' infringement has been willfuland deliberate;C. That this Court enter an order that the Tuboplast CTL Defendants andtheir officers, agents, servants, employees, successors, and assigns, and thosepersons acting in concert with them, be preliminarily and permanently enjoinedfrom infringing or actively inducing others to infringe the '094 Patent;D. That this Court award costs and damages, in an amount to bedetermined at trial, to Plaintif to compensate them for the Tuboplast CTLDefendants' unlawful infringement of the '094Patent;E. That this Court award interest on such damages to Plaintif;F. That this Court award enhanced damages to Plaintiffs pursuant to 35u.s.c. $ 284;G. That this Court determine that this patent infringement case isexceptional and award Plaintif their expenses and afforneys' fees incurred in thisaction pursuant to 35 U.S.C. $ 285; andH. That this Court award such other relief as this Court deems just andproper.

iltilt

- 8 - coMPLATNT



9/40

slcFIlu

12J456789

1011t213t415t6l718T9202l22232425262728

DEMAND FOR JURY TRIALPlaintiffs respectfully request a trial by j,r.y on all issues triable

therebyDated: May 10,2013 SNELL & WILMER L.L.PWilliam S. O'HareDeborah S. Mallgrave

PAUL WE,ISS RIFKIND WFIARTON& GARzuSON L.L.P.Catherine NyaradyQtro hac vice pending)Alexander B. Parker (SBN 264705)

By:

r7r4'1894.1

iam S. O'HareDeborah S. MallgraveAttorneys for PlaintffiViva Healthcare Packagi ng, Ltd., VivaHealthcare Packaging (FIK) Ltd., andViva Healthcare Packaging (USA) Inc.

-9 - COMPLAINT



10/40

EXHIBT A

EXH|B|T A, PAGE Jd



11/40

Case 2:13 cv 03372 SVW MRW Document 1 Filed 05/10/13 Page 12 of 40 Page ID #:25


12/40

LJ.S. Patent Apr. L5,2003 Sheet I of 12 us 6,547,094 B1

c\(5t

r5u-

Exhibit A, Pg. 12




13/40

LJ.S. Patent Apr. 15,2003 Sheet 2 oT 12 us 6,547,094 8L

-sL9LL

IYt9tL

Exhibit A, Pg. 13




14/40

IJ.S. Patent Apr. 15,2003 Sheet 3 of L2 us 6,547,094 B1

\o19lJ-

ln(9u-Exhibit A, Pg. 14

Case 2:13 cv 03372 SVW MRW Document 1 Filed 05/10/13 Page 14 of 40 Page ID #:27



15/40

IJ.S. Patent Apr. 15,2003 Sheet 4 of 12 us 6,547,094 Bl

l(5lLr- I

fr.'(:fEExhibit A, Ps. 15

g g



16/40

-\

IJ.S. Patent Apr. 1"5,2003 Sheet 5 of L2 us 6,547,094 B1

o\a(5,

Exhibit A, Pg. 16



17/40

LJ.S. Patent Apr. 15,2003 Sheet 6 or 12 us 6,547,094 B1

-oOr(9iT

foos-L?u-

Exhibt A, Pg. 17



18/40

I-J.S. Patent Apr. 15,2003 sheet 7 or 12 us 6,547,094 81

-xt- Nt-

C\

(\>

viva healthcare packaging et. al. v. ctl packaging et. al

Documents